These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22359620)

  • 21. Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas.
    Manda SV; Kataria Y; Tatireddy BR; Ramakrishnan B; Ratnam BG; Lath R; Ranjan A; Ray A
    J Neurosurg; 2018 Apr; 128(4):1091-1101. PubMed ID: 28574310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.
    Van Damme N; Deron P; Van Roy N; Demetter P; Bols A; Van Dorpe J; Baert F; Van Laethem JL; Speleman F; Pauwels P; Peeters M
    BMC Cancer; 2010 May; 10():189. PubMed ID: 20459770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics.
    Jeuken J; Sijben A; Alenda C; Rijntjes J; Dekkers M; Boots-Sprenger S; McLendon R; Wesseling P
    Brain Pathol; 2009 Oct; 19(4):661-71. PubMed ID: 19744038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response.
    Boeckx C; Weyn C; Vanden Bempt I; Deschoolmeester V; Wouters A; Specenier P; Van Laer C; Van den Weyngaert D; Kockx M; Vermorken JB; Peeters M; Pauwels P; Lardon F; Baay M
    BMC Res Notes; 2014 Jun; 7():337. PubMed ID: 24899223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
    Uribe P; Gonzalez S
    Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.
    Klimowicz AC; Bose P; Nakoneshny SC; Dean M; Huang L; Chandarana S; Magliocco AM; Wayne Matthews T; Brockton NT; Dort JC
    Eur J Cancer; 2012 Sep; 48(14):2166-74. PubMed ID: 22892062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma.
    Chuerduangphui J; Pientong C; Patarapadungkit N; Chotiyano A; Vatanasapt P; Kongyingyoes B; Promthet S; Swangphon P; Bumrungthai S; Pimson C; Ekalaksananan T
    Med Oncol; 2017 Sep; 34(9):148. PubMed ID: 28741068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction.
    Zhong LP; Zhao SF; Chen GF; Ping FY; Xu ZF; Hu JA
    Arch Oral Biol; 2006 Dec; 51(12):1112-9. PubMed ID: 16806049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of human papillomavirus in p16-positive oral cancers.
    Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
    J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas.
    Smilek P; Neuwirthova J; Jarkovsky J; Dusek L; Rottenberg J; Kostrica R; Srovnal J; Hajduch M; Drabek J; Klozar J
    Neoplasma; 2012; 59(5):508-15. PubMed ID: 22668015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts.
    Johnson H; Del Rosario AM; Bryson BD; Schroeder MA; Sarkaria JN; White FM
    Mol Cell Proteomics; 2012 Dec; 11(12):1724-40. PubMed ID: 22964225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of circulating cancer cells in human oral squamous cell carcinoma.
    Zen H; Nakashiro K; Shintani S; Sumida T; Aramoto T; Hamakawa H
    Int J Oncol; 2003 Sep; 23(3):605-10. PubMed ID: 12888894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGFR and EGFRvIII expression in primary breast cancer and cell lines.
    Rae JM; Scheys JO; Clark KM; Chadwick RB; Kiefer MC; Lippman ME
    Breast Cancer Res Treat; 2004 Sep; 87(1):87-95. PubMed ID: 15377854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
    Christensen A; Kiss K; Lelkaitis G; Juhl K; Persson M; Charabi BW; Mortensen J; Forman JL; Sørensen AL; Jensen DH; Kjaer A; von Buchwald C
    BMC Cancer; 2017 Aug; 17(1):572. PubMed ID: 28841839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
    Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
    BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens.
    Asaka S; Yoshizawa A; Matsuda K; Yamaguchi A; Yamamoto H; Shiina T; Nakata R; Ogawa K; Zhang M; Honda T
    Oncol Rep; 2017 Feb; 37(2):1020-1026. PubMed ID: 27922678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.
    Taoudi Benchekroun M; Saintigny P; Thomas SM; El-Naggar AK; Papadimitrakopoulou V; Ren H; Lang W; Fan YH; Huang J; Feng L; Lee JJ; Kim ES; Hong WK; Johnson FM; Grandis JR; Mao L
    Cancer Prev Res (Phila); 2010 Jul; 3(7):800-9. PubMed ID: 20570883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.
    Tinhofer I; Klinghammer K; Weichert W; Knödler M; Stenzinger A; Gauler T; Budach V; Keilholz U
    Clin Cancer Res; 2011 Aug; 17(15):5197-204. PubMed ID: 21653686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.
    Wheeler SE; Morariu EM; Bednash JS; Otte CG; Seethala RR; Chiosea SI; Grandis JR
    Clin Cancer Res; 2012 May; 18(10):2850-60. PubMed ID: 22490227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
    Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
    J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.